Elixinol Wellness Ltd (ASX:EXL)
A$ 0.004 0 (0%) Market Cap: 5.20 Mil Enterprise Value: 5.76 Mil PE Ratio: 0 PB Ratio: 0.50 GF Score: 0/100

ELIXINOL TO ACQUIRE CANNACARE HEALTH CALL Transcript

Mar 16, 2021 / 12:00AM GMT
Release Date Price: A$0.163333
Juliana Roadley;Oliver Horn
IR Department - IR;

Good morning, everybody, and welcome to Elixinol Global's special investor briefing. My name is Juliana Roadley, and I'm an Account Director at the IR Department. It is a pleasure to be supporting Elixinol with Investor Relations through this exciting time. Presenting today will be Oliver Horn, the Global Chief Executive and Executive Directing Officer; and also Ron Dufficy, who is the Chief Financial Officer to discuss Elixinol's signing of a binding agreement to acquire CannaCare.

Now the formal part of the session will be followed by Q&A. If you would like to ask a question, we would ask that you keep those questions until the end of the briefing. And if you type them into the space below, in the band at the bottom of the screen, and we'll be able to answer those questions for you. Just to let you know that this session will be recorded today, and the recording will be available online on the Elixinol website after the event.

Now, I'd like to hand over to the CEO, Oliver Horn. Thank you, Oliver.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot